TRANEXAMIC ACID

TRANEXAMIC ACID was reported 9077 times

TRANEXAMIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MECHANICAL VENTILATION COMPLICATION 25 0.1678
1 POST PROCEDURAL HYPOTENSION 11 0.1294
2 INSPIRATORY CAPACITY DECREASED 26 0.0939
3 PUNCTURE SITE HAEMATOMA 6 0.0938
4 FACTOR VII DEFICIENCY 6 0.0896
5 RENAL CORTICAL NECROSIS 17 0.0730
6 MESENTERIC VASCULAR INSUFFICIENCY 7 0.0636
7 OVARIAN VEIN THROMBOSIS 8 0.0530
8 RED BLOOD CELL TRANSFUSION 16 0.0390
9 HAEMOPHILIA 8 0.0374
10 FALLOPIAN TUBE DISORDER 11 0.0373
11 TRI-IODOTHYRONINE FREE DECREASED 9 0.0353
12 ADNEXAL TORSION 11 0.0347
13 ELECTROCARDIOGRAM PR SHORTENED 7 0.0333
14 CONGENITAL ORAL MALFORMATION 7 0.0320
15 PARENTERAL NUTRITION 7 0.0303
16 MATERNAL EXPOSURE DURING DELIVERY 30 0.0303
17 BILIARY SEPSIS 14 0.0302
18 DISABILITY ASSESSMENT SCALE SCORE INCREASED 9 0.0293
19 HAEMOPHILIC ARTHROPATHY 7 0.0293
20 FIBRIN DEGRADATION PRODUCTS INCREASED 8 0.0270
21 ENTEROCOCCAL SEPSIS 21 0.0259
22 CEREBRAL VENOUS SINUS THROMBOSIS 21 0.0249
23 DREAMY STATE 7 0.0216
24 ACUTE LEFT VENTRICULAR FAILURE 14 0.0208
25 APLASTIC ANAEMIA 105 0.0201
26 JOINT ANKYLOSIS 11 0.0194
27 INFUSION SITE SCAR 8 0.0181
28 MYOCLONIC EPILEPSY 27 0.0178
29 HAEMOTHORAX 51 0.0176
30 FACTOR VIII INHIBITION 18 0.0171
31 HER2 POSITIVE BREAST CANCER 6 0.0160
32 PLATELET TRANSFUSION 20 0.0155
33 BASOPHIL COUNT INCREASED 10 0.0132
34 WRONG PRODUCT ADMINISTERED 88 0.0130
35 VASODILATATION 32 0.0127
36 PERFORATION 10 0.0124
37 FIBROMA 11 0.0120
38 CORONARY ARTERY THROMBOSIS 24 0.0119
39 POSTPARTUM HAEMORRHAGE 16 0.0119
40 CEREBRAL ARTERY THROMBOSIS 6 0.0117
41 BRONCHIAL HYPERREACTIVITY 14 0.0116
42 HEREDITARY ANGIOEDEMA 124 0.0115
43 URINE LEUKOCYTE ESTERASE POSITIVE 8 0.0114
44 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 12 0.0113
45 MYOCLONUS 133 0.0111
46 NEUROGENIC SHOCK 6 0.0111
47 HAEMORRHAGIC DISORDER 12 0.0110
48 STRIDOR 32 0.0109
49 PRODUCT APPEARANCE CONFUSION 10 0.0108
50 NEONATAL RESPIRATORY DISTRESS 10 0.0106
51 PRODUCT PACKAGING CONFUSION 25 0.0103
52 HYPORESPONSIVE TO STIMULI 12 0.0102
53 PLASMA CELL LEUKAEMIA 6 0.0100
54 PUNCTURE SITE HAEMORRHAGE 7 0.0099
55 UTERINE DISORDER 23 0.0099
56 VASCULAR STENT THROMBOSIS 20 0.0098
57 DYSCHROMATOPSIA 8 0.0097
58 ARTERIAL HAEMORRHAGE 11 0.0096
59 IMMUNE THROMBOCYTOPENIA 43 0.0094
60 ABSCESS ORAL 12 0.0087
61 INFUSION SITE DISCOMFORT 9 0.0087
62 STATUS EPILEPTICUS 95 0.0084
63 RETINAL ARTERY OCCLUSION 21 0.0083
64 PCO2 DECREASED 8 0.0083
65 SHOCK HAEMORRHAGIC 67 0.0082
66 SPONTANEOUS HAEMORRHAGE 8 0.0078
67 GASTROINTESTINAL VIRAL INFECTION 8 0.0077
68 NAIL INFECTION 11 0.0077
69 JOINT NOISE 15 0.0076
70 BLOOD FIBRINOGEN INCREASED 6 0.0076
71 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 10 0.0076
72 SYSTOLIC DYSFUNCTION 8 0.0076
73 UPPER RESPIRATORY TRACT INFLAMMATION 9 0.0075
74 HAEMOPERITONEUM 6 0.0075
75 INFERTILITY 11 0.0073
76 SLEEP DEFICIT 15 0.0071
77 LOWER RESPIRATORY TRACT CONGESTION 12 0.0071
78 URINE KETONE BODY PRESENT 11 0.0070
79 GENERALISED TONIC-CLONIC SEIZURE 113 0.0068
80 NOSOCOMIAL INFECTION 15 0.0068
81 OESOPHAGEAL HAEMORRHAGE 9 0.0068
82 LABILE BLOOD PRESSURE 8 0.0067
83 INFUSION SITE WARMTH 8 0.0065
84 COAGULATION TIME PROLONGED 10 0.0065
85 BRAIN STEM HAEMORRHAGE 6 0.0063
86 UTERINE HAEMORRHAGE 27 0.0063
87 HEAVY MENSTRUAL BLEEDING 56 0.0062
88 BLOOD FIBRINOGEN DECREASED 7 0.0061
89 ISCHAEMIC CEREBRAL INFARCTION 7 0.0060
90 PROCALCITONIN INCREASED 7 0.0060
91 EMBOLISM VENOUS 18 0.0059
92 NEUTROPENIC SEPSIS 42 0.0059
93 VENOOCCLUSIVE LIVER DISEASE 29 0.0059
94 CANCER PAIN 15 0.0059
95 INFUSION SITE RASH 8 0.0058
96 HYPOVOLAEMIA 34 0.0058
97 MUSCLE HAEMORRHAGE 22 0.0055
98 HAEMOGLOBIN INCREASED 25 0.0055
99 TONIC CLONIC MOVEMENTS 7 0.0054
100 PULMONARY HAEMORRHAGE 42 0.0054
101 JAUNDICE NEONATAL 10 0.0053
102 ADMINISTRATION SITE PAIN 6 0.0052
103 OLIGOMENORRHOEA 11 0.0050
104 PULSELESS ELECTRICAL ACTIVITY 21 0.0050
105 ANGIOPATHY 28 0.0050
106 PERIPHERAL ARTERY THROMBOSIS 7 0.0050
107 PLATELET COUNT ABNORMAL 30 0.0050
108 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 85 0.0050
109 PHARYNGEAL HAEMORRHAGE 6 0.0049
110 HAEMODYNAMIC INSTABILITY 37 0.0049
111 VENA CAVA THROMBOSIS 8 0.0048
112 HAEMARTHROSIS 43 0.0048
113 CLONUS 13 0.0047
114 BLOOD PRESSURE DIASTOLIC ABNORMAL 12 0.0047
115 TENOSYNOVITIS 13 0.0047
116 GASTROINTESTINAL WALL THICKENING 7 0.0047
117 HAEMORRHAGIC TRANSFORMATION STROKE 7 0.0046
118 PURPURA 41 0.0046
119 ISCHAEMIA 21 0.0046
120 TUMOUR HAEMORRHAGE 13 0.0046
121 HAEMORRHAGIC DIATHESIS 16 0.0045
122 CYSTITIS HAEMORRHAGIC 18 0.0045
123 BLOOD LOSS ANAEMIA 10 0.0044
124 ATRIAL THROMBOSIS 9 0.0043
125 DISINHIBITION 7 0.0043
126 PROCEDURAL HAEMORRHAGE 17 0.0043
127 TRANSFUSION 45 0.0043
128 PROTHROMBIN TIME SHORTENED 6 0.0043
129 ANAPHYLACTIC REACTION 235 0.0042
130 TRAUMATIC HAEMORRHAGE 8 0.0042
131 INTENSIVE CARE 6 0.0042
132 URINARY TRACT OBSTRUCTION 10 0.0042
133 MUCOSAL INFLAMMATION 110 0.0042
134 POOR VENOUS ACCESS 43 0.0042
135 FINE MOTOR SKILL DYSFUNCTION 12 0.0041
136 ARTERIAL THROMBOSIS 8 0.0041
137 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
138 AUTONOMIC NERVOUS SYSTEM IMBALANCE 12 0.0041
139 PULMONARY ALVEOLAR HAEMORRHAGE 23 0.0041
140 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 9 0.0041
141 BACTERIAL TEST POSITIVE 9 0.0040
142 FEBRILE NEUTROPENIA 267 0.0040
143 ANAPHYLACTIC SHOCK 103 0.0040
144 RHEUMATOID NODULE 11 0.0040
145 HYPOVENTILATION 13 0.0040
146 PLEURITIC PAIN 11 0.0040
147 PLATELET DISORDER 10 0.0040
148 IMMUNE THROMBOCYTOPENIC PURPURA 11 0.0039
149 POST PROCEDURAL HAEMORRHAGE 45 0.0039
150 PLATELET COUNT INCREASED 50 0.0038
151 HYPERTRICHOSIS 7 0.0038
152 COAGULOPATHY 62 0.0037
153 LANGUAGE DISORDER 8 0.0037
154 PERIORBITAL OEDEMA 19 0.0037
155 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
156 UTERINE LEIOMYOMA 26 0.0036
157 CEREBELLAR INFARCTION 6 0.0035
158 PNEUMONIA FUNGAL 14 0.0035
159 OXYGEN SATURATION ABNORMAL 10 0.0035
160 ALLERGIC REACTION TO EXCIPIENT 7 0.0035
161 ABNORMAL UTERINE BLEEDING 9 0.0035
162 BLOOD CHLORIDE INCREASED 6 0.0035
163 STAPHYLOCOCCAL SEPSIS 17 0.0034
164 HAEMOPTYSIS 96 0.0034
165 PERIPHERAL ISCHAEMIA 14 0.0034
166 MOUTH HAEMORRHAGE 25 0.0034
167 EMBOLIC STROKE 12 0.0034
168 MELAENA 75 0.0034
169 VENTRICULAR FIBRILLATION 37 0.0033
170 VENOUS THROMBOSIS 13 0.0033
171 STRESS CARDIOMYOPATHY 19 0.0033
172 AMYLASE INCREASED 12 0.0032
173 SPUTUM INCREASED 7 0.0032
174 ONYCHOMYCOSIS 14 0.0032
175 PARESIS 7 0.0031
176 THROMBOPHLEBITIS 11 0.0031
177 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7 0.0031
178 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
179 MENINGITIS ASEPTIC 14 0.0031
180 HEPATOSPLENOMEGALY 8 0.0031
181 FOOD ALLERGY 24 0.0031
182 FIBRIN D DIMER INCREASED 11 0.0031
183 VASCULAR DEVICE INFECTION 14 0.0031
184 LARYNGEAL OEDEMA 19 0.0031
185 CEREBRAL INFARCTION 75 0.0031
186 APLASIA 6 0.0031
187 RASH MACULO-PAPULAR 68 0.0031
188 DISSEMINATED INTRAVASCULAR COAGULATION 43 0.0031
189 HAEMORRHAGE 317 0.0030
190 BRAIN OEDEMA 38 0.0030
191 EMPHYSEMA 30 0.0030
192 PULMONARY INFARCTION 7 0.0030
193 ENTEROCOLITIS 17 0.0029
194 NORMAL NEWBORN 16 0.0029
195 CIRCULATORY COLLAPSE 50 0.0029
196 INTRACARDIAC THROMBUS 9 0.0029
197 PNEUMOTHORAX 46 0.0029
198 IRON DEFICIENCY 13 0.0029
199 HYPOPNOEA 10 0.0029
200 URINE ABNORMALITY 13 0.0029
201 NEUROTOXICITY 50 0.0029
202 INFUSION SITE PRURITUS 9 0.0028
203 ELECTROENCEPHALOGRAM ABNORMAL 9 0.0028
204 ACUTE MYOCARDIAL INFARCTION 84 0.0028
205 HYPOPHOSPHATAEMIA 21 0.0028
206 THROMBOTIC THROMBOCYTOPENIC PURPURA 10 0.0028
207 HAEMORRHAGE SUBCUTANEOUS 10 0.0028
208 BLOOD PRESSURE DIASTOLIC INCREASED 13 0.0028
209 GRAND MAL CONVULSION 26 0.0028
210 CATHETER SITE HAEMORRHAGE 7 0.0028
211 VENOOCCLUSIVE DISEASE 7 0.0028
212 GINGIVAL BLEEDING 38 0.0028
213 BACTERAEMIA 33 0.0028
214 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 14 0.0027
215 ANGIOEDEMA 119 0.0027
216 COMPARTMENT SYNDROME 7 0.0027
217 EXTRAVASATION 11 0.0027
218 FACE OEDEMA 45 0.0027
219 COLITIS ISCHAEMIC 18 0.0027
220 URINARY TRACT DISORDER 12 0.0027
221 RADICULOPATHY 7 0.0027
222 HYPERCAPNIA 8 0.0027
223 CENTRAL VENOUS CATHETERISATION 8 0.0026
224 MOUTH SWELLING 15 0.0026
225 HYPERREFLEXIA 9 0.0026
226 CONCUSSION 20 0.0026
227 BRONCHOPULMONARY ASPERGILLOSIS 20 0.0026
228 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 14 0.0026
229 ACUTE MYELOID LEUKAEMIA 40 0.0026
230 BLOOD BLISTER 8 0.0026
231 PHARYNGEAL SWELLING 25 0.0026
232 ESCHERICHIA BACTERAEMIA 6 0.0025
233 SINUS TACHYCARDIA 36 0.0025
234 DIABETES INSIPIDUS 6 0.0025
235 PARTIAL SEIZURES 13 0.0025
236 VENTRICULAR ARRHYTHMIA 9 0.0025
237 NYSTAGMUS 13 0.0024
238 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 19 0.0024
239 ANAPHYLACTOID REACTION 10 0.0024
240 PRODUCT LABEL CONFUSION 14 0.0024
241 LOW BIRTH WEIGHT BABY 19 0.0024
242 OSTEITIS 6 0.0024
243 UPPER GASTROINTESTINAL HAEMORRHAGE 40 0.0024
244 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 12 0.0024
245 THROMBOTIC MICROANGIOPATHY 23 0.0024
246 TONGUE OEDEMA 9 0.0024
247 WEIGHT LOSS POOR 12 0.0023
248 BRAIN HERNIATION 7 0.0023
249 HAEMORRHAGE INTRACRANIAL 35 0.0023
250 DEVICE RELATED INFECTION 36 0.0023
251 MULTIPLE ORGAN DYSFUNCTION SYNDROME 66 0.0023
252 VIRAL UPPER RESPIRATORY TRACT INFECTION 11 0.0023
253 HYPERAESTHESIA 19 0.0023
254 BRONCHOSPASM 33 0.0023
255 HYPOXIA 81 0.0023
256 EPISTAXIS 171 0.0023
257 BLOOD ALBUMIN DECREASED 18 0.0023
258 VULVOVAGINAL DISCOMFORT 10 0.0023
259 OESOPHAGEAL CANDIDIASIS 9 0.0023
260 BLOOD DISORDER 18 0.0022
261 ISCHAEMIC STROKE 40 0.0022
262 CARDIOGENIC SHOCK 32 0.0022
263 HYPERTHERMIA 17 0.0022
264 MATERNAL EXPOSURE DURING BREAST FEEDING 9 0.0022
265 VAGINAL HAEMORRHAGE 96 0.0022
266 HAEMATOMA 57 0.0022
267 POLYURIA 18 0.0022
268 HEPATIC CYTOLYSIS 28 0.0022
269 VENTRICULAR HYPOKINESIA 7 0.0022
270 PROCTALGIA 14 0.0022
271 SHOCK 50 0.0022
272 WOUND HAEMORRHAGE 8 0.0022
273 CYANOSIS 34 0.0022
274 BACTERIAL SEPSIS 7 0.0021
275 HYPERACUSIS 8 0.0021
276 NEUTROPHIL COUNT INCREASED 22 0.0021
277 MYELODYSPLASTIC SYNDROME 31 0.0021
278 RIGHT VENTRICULAR FAILURE 15 0.0021
279 CEREBRAL ISCHAEMIA 11 0.0021
280 PULMONARY EMBOLISM 199 0.0021
281 TACHYCARDIA 186 0.0021
282 PNEUMOCYSTIS JIROVECII PNEUMONIA 21 0.0021
283 PLATELET COUNT DECREASED 222 0.0021
284 LUNG CANCER METASTATIC 6 0.0021
285 HYPOALBUMINAEMIA 16 0.0021
286 WOUND SECRETION 8 0.0020
287 ADVERSE REACTION 27 0.0020
288 LIVE BIRTH 17 0.0020
289 DEPRESSION SUICIDAL 7 0.0020
290 ILEUS PARALYTIC 9 0.0020
291 PREMATURE DELIVERY 32 0.0020
292 PROTHROMBIN TIME PROLONGED 12 0.0020
293 AZOTAEMIA 8 0.0020
294 OVARIAN CYST 20 0.0020
295 VENTRICULAR TACHYCARDIA 33 0.0020
296 SUSPECTED OFF LABEL USE 9 0.0020
297 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
298 OBSTRUCTIVE AIRWAYS DISORDER 22 0.0020
299 THERAPEUTIC PRODUCT EFFECT DELAYED 9 0.0020
300 MYOPATHY 17 0.0020
301 BLOOD BILIRUBIN INCREASED 53 0.0020
302 URINE OUTPUT DECREASED 17 0.0019
303 CONCOMITANT DISEASE AGGRAVATED 12 0.0019
304 TUMOUR LYSIS SYNDROME 17 0.0019
305 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
306 FOOD INTOLERANCE 7 0.0019
307 INFUSION SITE SWELLING 12 0.0019
308 PARADOXICAL DRUG REACTION 7 0.0019
309 SENSITIVITY TO WEATHER CHANGE 10 0.0019
310 SEIZURE 219 0.0019
311 SKIN EROSION 6 0.0019
312 PROTEIN TOTAL DECREASED 7 0.0019
313 PORTAL VEIN THROMBOSIS 6 0.0019
314 PLEURISY 11 0.0019
315 PAPULE 13 0.0018
316 DERMATITIS CONTACT 21 0.0018
317 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
318 BLOOD LACTATE DEHYDROGENASE INCREASED 29 0.0018
319 INTESTINAL ISCHAEMIA 10 0.0018
320 BLOOD CREATINE INCREASED 8 0.0018
321 HEPATIC FUNCTION ABNORMAL 67 0.0018
322 CARDIAC ARREST 148 0.0018
323 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17 0.0018
324 BK VIRUS INFECTION 6 0.0018
325 HAEMATEMESIS 45 0.0018
326 CHOLESTASIS 34 0.0018
327 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 9 0.0018
328 FEMORAL NECK FRACTURE 9 0.0018
329 ONYCHOCLASIS 12 0.0017
330 HYPOKALAEMIA 80 0.0017
331 PREMATURE BABY 52 0.0017
332 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
333 ACIDOSIS 13 0.0017
334 HYPOTENSION 340 0.0017
335 DIFFUSE LARGE B-CELL LYMPHOMA 13 0.0017
336 EMBOLISM 14 0.0017
337 HAEMOLYSIS 13 0.0017
338 HAEMOLYTIC ANAEMIA 15 0.0017
339 LIP OEDEMA 7 0.0017
340 OESOPHAGITIS 18 0.0016
341 DEEP VEIN THROMBOSIS 107 0.0016
342 THROMBOCYTOPENIA 184 0.0016
343 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
344 LYMPHOCYTE COUNT DECREASED 29 0.0016
345 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 90 0.0016
346 HAEMOGLOBIN DECREASED 168 0.0016
347 PNEUMONIA BACTERIAL 15 0.0016
348 PETECHIAE 17 0.0016
349 STEVENS-JOHNSON SYNDROME 36 0.0016
350 TACHYPNOEA 22 0.0016
351 BLOOD UREA INCREASED 27 0.0016
352 INTERMENSTRUAL BLEEDING 9 0.0016
353 ILEUS 20 0.0016
354 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
355 ALANINE AMINOTRANSFERASE INCREASED 98 0.0016
356 C-REACTIVE PROTEIN INCREASED 58 0.0016
357 PANCYTOPENIA 89 0.0016
358 CEREBRAL HAEMORRHAGE 57 0.0016
359 MUSCLE RIGIDITY 19 0.0016
360 RECTAL HAEMORRHAGE 68 0.0016
361 ESCHERICHIA INFECTION 13 0.0016
362 PLEURAL EFFUSION 96 0.0016
363 ADRENAL INSUFFICIENCY 19 0.0016
364 EOSINOPHIL COUNT INCREASED 13 0.0016
365 CAESAREAN SECTION 18 0.0015
366 FEELING OF BODY TEMPERATURE CHANGE 9 0.0015
367 GASTROINTESTINAL HAEMORRHAGE 128 0.0015
368 OXYGEN SATURATION DECREASED 86 0.0015
369 DRUG ERUPTION 27 0.0015
370 BLOOD IRON DECREASED 18 0.0015
371 NEPHROGENIC ANAEMIA 7 0.0015
372 SWOLLEN TONGUE 47 0.0015
373 DELIRIUM 52 0.0015
374 TOXIC SKIN ERUPTION 15 0.0015
375 ANAL ABSCESS 8 0.0015
376 INFUSION SITE PAIN 19 0.0015
377 HIATUS HERNIA 19 0.0015
378 ENTEROCOCCAL INFECTION 7 0.0014
379 RASH ERYTHEMATOUS 69 0.0014
380 HAEMORRHOIDAL HAEMORRHAGE 7 0.0014
381 SEPSIS 159 0.0014
382 APHASIA 43 0.0014
383 BLOOD THYROID STIMULATING HORMONE INCREASED 13 0.0014
384 INFLAMMATORY MARKER INCREASED 7 0.0014
385 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
386 ACUTE RESPIRATORY FAILURE 27 0.0014
387 MYDRIASIS 18 0.0014
388 PSEUDOMONAS INFECTION 12 0.0014
389 HYPERPROLACTINAEMIA 9 0.0014
390 HEPATITIS ACUTE 9 0.0014
391 DERMATITIS BULLOUS 10 0.0014
392 MATERNAL EXPOSURE DURING PREGNANCY 123 0.0014
393 THERAPY NON-RESPONDER 62 0.0014
394 VASCULITIS 16 0.0014
395 GENERALISED OEDEMA 17 0.0014
396 WALKING AID USER 9 0.0014
397 INTERSTITIAL LUNG DISEASE 66 0.0014
398 PNEUMONIA ASPIRATION 34 0.0014
399 HEMIPARESIS 23 0.0014
400 WRONG DRUG ADMINISTERED 12 0.0013
401 ODYNOPHAGIA 8 0.0013
402 HYDRONEPHROSIS 10 0.0013
403 SEPTIC SHOCK 58 0.0013
404 POSTOPERATIVE WOUND INFECTION 9 0.0013
405 MULTI-ORGAN FAILURE 23 0.0013
406 MATERNAL EXPOSURE BEFORE PREGNANCY 9 0.0013
407 EPILEPSY 40 0.0013
408 RESPIRATORY DISTRESS 36 0.0013
409 TRANSAMINASES INCREASED 29 0.0013
410 BLOOD PRESSURE DECREASED 86 0.0013
411 GASTRITIS 34 0.0013
412 CHOLANGITIS 8 0.0013
413 DEPRESSED LEVEL OF CONSCIOUSNESS 51 0.0013
414 SUBARACHNOID HAEMORRHAGE 13 0.0013
415 GASTRIC ULCER HAEMORRHAGE 7 0.0013
416 GESTATIONAL DIABETES 6 0.0013
417 ANAEMIA 240 0.0013
418 NECROSIS 7 0.0013
419 AMENORRHOEA 22 0.0013
420 ACUTE PULMONARY OEDEMA 7 0.0012
421 LUNG INFILTRATION 11 0.0012
422 HEPATITIS C 15 0.0012
423 DIZZINESS POSTURAL 12 0.0012
424 RASH PUSTULAR 9 0.0012
425 PERONEAL NERVE PALSY 7 0.0012
426 NEUTROPHIL COUNT DECREASED 50 0.0012
427 MENORRHAGIA 24 0.0012
428 GASTRIC HAEMORRHAGE 14 0.0012
429 ORAL CANDIDIASIS 16 0.0012
430 THROMBOSIS 96 0.0012
431 IRON DEFICIENCY ANAEMIA 11 0.0012
432 EXPOSURE DURING PREGNANCY 74 0.0012
433 KLEBSIELLA INFECTION 6 0.0012
434 TROPONIN INCREASED 9 0.0012
435 BACTERIAL INFECTION 22 0.0012
436 DEFORMITY 11 0.0012
437 FOOT DEFORMITY 13 0.0012
438 HAEMATURIA 40 0.0012
439 CACHEXIA 6 0.0012
440 GASTROENTERITIS 17 0.0012
441 HYPOCALCAEMIA 22 0.0012
442 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
443 HYPERBILIRUBINAEMIA 12 0.0012
444 PRURITUS GENERALISED 25 0.0012
445 TENDERNESS 12 0.0012
446 WHITE BLOOD CELL COUNT INCREASED 44 0.0011
447 PALLOR 31 0.0011
448 SERUM FERRITIN INCREASED 6 0.0011
449 DUODENAL ULCER 8 0.0011
450 PULMONARY TOXICITY 8 0.0011
451 ASPARTATE AMINOTRANSFERASE INCREASED 60 0.0011
452 PHARYNGITIS 14 0.0011
453 RESPIRATORY RATE INCREASED 10 0.0011
454 METABOLIC ACIDOSIS 36 0.0011
455 ACUTE KIDNEY INJURY 171 0.0011
456 LIGAMENT SPRAIN 11 0.0011
457 BRADYCARDIA 59 0.0011
458 HAEMATOCRIT DECREASED 22 0.0011
459 RENAL FAILURE ACUTE 47 0.0011
460 BLOOD URINE PRESENT 21 0.0011
461 DRUG INTERACTION 175 0.0011
462 SALIVARY HYPERSECRETION 11 0.0011
463 UROSEPSIS 10 0.0011
464 NERVE INJURY 12 0.0011
465 PRODUCT DISTRIBUTION ISSUE 10 0.0011
466 PYREXIA 373 0.0011
467 NODULE 14 0.0011
468 MALNUTRITION 12 0.0011
469 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
470 RESPIRATORY DEPRESSION 13 0.0011
471 NEUROLOGICAL SYMPTOM 6 0.0010
472 TOOTHACHE 19 0.0010
473 PARALYSIS 15 0.0010
474 SUBDURAL HAEMATOMA 15 0.0010
475 ANURIA 9 0.0010
476 JOINT RANGE OF MOTION DECREASED 14 0.0010
477 POST PROCEDURAL COMPLICATION 20 0.0010
478 PHARYNGEAL OEDEMA 16 0.0010
479 FULL BLOOD COUNT ABNORMAL 11 0.0010
480 BLOOD URIC ACID INCREASED 6 0.0010
481 RESPIRATORY FAILURE 75 0.0010
482 HEPATIC FAILURE 31 0.0010
483 ACUTE HEPATIC FAILURE 14 0.0010
484 SPLENOMEGALY 12 0.0010
485 ASCITES 30 0.0010
486 KIDNEY INFECTION 20 0.0010
487 CONTUSION 98 0.0010
488 PRODUCT PRESCRIBING ISSUE 22 0.0010
489 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
490 HYPOMAGNESAEMIA 14 0.0010
491 PULMONARY OEDEMA 45 0.0010
492 GASTROENTERITIS VIRAL 18 0.0010
493 LEUKOCYTOSIS 18 0.0010
494 BODY TEMPERATURE INCREASED 20 0.0010
495 CYTOPENIA 12 0.0010
496 URTICARIA 164 0.0010
497 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
498 IMPAIRED QUALITY OF LIFE 14 0.0010
499 GRAFT VERSUS HOST DISEASE 7 0.0010
500 PARAESTHESIA ORAL 14 0.0010
501 EOSINOPHILIA 17 0.0010
502 SPINAL COMPRESSION FRACTURE 8 0.0010
503 THERAPY PARTIAL RESPONDER 15 0.0010
504 DISORIENTATION 38 0.0010
505 CARDIO-RESPIRATORY ARREST 40 0.0010
506 ARTERIOSCLEROSIS 9 0.0010
507 INFUSION SITE ERYTHEMA 8 0.0009
508 SYNCOPE 94 0.0009
509 FACIAL PARALYSIS 8 0.0009
510 ENCEPHALOPATHY 23 0.0009
511 COVID-19 PNEUMONIA 11 0.0009
512 ATELECTASIS 9 0.0009
513 JAUNDICE 25 0.0009
514 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
515 PRODUCT PREPARATION ISSUE 6 0.0009
516 ASPERGILLUS INFECTION 6 0.0009
517 WOUND INFECTION 10 0.0009
518 HYPERKALAEMIA 32 0.0009
519 HYPONATRAEMIA 51 0.0009
520 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
521 CYTOMEGALOVIRUS INFECTION 15 0.0009
522 FUNGAL INFECTION 30 0.0009
523 URINARY RETENTION 30 0.0009
524 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
525 TORSADE DE POINTES 7 0.0009
526 SKIN INFECTION 10 0.0009
527 UNRESPONSIVE TO STIMULI 23 0.0009
528 BONE MARROW FAILURE 18 0.0009
529 MOTOR DYSFUNCTION 9 0.0009
530 MYOCARDIAL ISCHAEMIA 10 0.0009
531 PRESCRIBED OVERDOSE 17 0.0009
532 ATRIAL FLUTTER 7 0.0009
533 JOINT STIFFNESS 23 0.0009
534 MIOSIS 7 0.0009
535 PNEUMONIA 282 0.0009
536 DRUG-INDUCED LIVER INJURY 27 0.0009
537 ERYTHEMA MULTIFORME 8 0.0009
538 APPENDICITIS 8 0.0009
539 DISEASE PROGRESSION 101 0.0009
540 FLANK PAIN 8 0.0009
541 CHILLS 100 0.0009
542 HAND FRACTURE 6 0.0008
543 ACUTE CORONARY SYNDROME 7 0.0008
544 PNEUMONITIS 23 0.0008
545 LIP SWELLING 28 0.0008
546 SEROTONIN SYNDROME 16 0.0008
547 DYSMENORRHOEA 11 0.0008
548 SKIN LACERATION 9 0.0008
549 WHEEZING 49 0.0008
550 PRODUCT CONTAINER ISSUE 7 0.0008
551 TOOTH FRACTURE 9 0.0008
552 HAEMATOCHEZIA 45 0.0008
553 HEPATOMEGALY 8 0.0008
554 SWELLING FACE 53 0.0008
555 LIMB INJURY 22 0.0008
556 HYPERCALCAEMIA 10 0.0008
557 PYELONEPHRITIS 7 0.0008
558 RED BLOOD CELL COUNT DECREASED 23 0.0008
559 HYPOTONIA 8 0.0008
560 LEUKOPENIA 40 0.0008
561 RENAL IMPAIRMENT 67 0.0008
562 MIGRAINE 76 0.0008
563 INTENTIONAL SELF-INJURY 16 0.0008
564 HYPOTHERMIA 8 0.0008
565 COORDINATION ABNORMAL 11 0.0008
566 FOETAL EXPOSURE DURING PREGNANCY 64 0.0008
567 PROCEDURAL COMPLICATION 6 0.0008
568 HYPOPHAGIA 20 0.0008
569 OEDEMA PERIPHERAL 95 0.0008
570 GENITAL HAEMORRHAGE 10 0.0008
571 PERITONITIS 16 0.0008
572 APNOEA 6 0.0008
573 HYPOKINESIA 11 0.0008
574 JOINT DISLOCATION 8 0.0008
575 LIVER FUNCTION TEST ABNORMAL 22 0.0008
576 AGRANULOCYTOSIS 14 0.0008
577 WOUND 21 0.0008
578 OFF LABEL USE 657 0.0007
579 HEPATIC ENCEPHALOPATHY 7 0.0007
580 PHOTOPHOBIA 14 0.0007
581 RHINITIS 6 0.0007
582 PRESYNCOPE 18 0.0007
583 DECUBITUS ULCER 6 0.0007
584 PERICARDIAL EFFUSION 17 0.0007
585 PULMONARY THROMBOSIS 8 0.0007
586 NEUTROPENIA 99 0.0007
587 ABDOMINAL PAIN 169 0.0007
588 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
589 LIVER DISORDER 32 0.0007
590 PULMONARY HYPERTENSION 15 0.0007
591 INTENTIONAL PRODUCT USE ISSUE 63 0.0007
592 ARRHYTHMIA 34 0.0007
593 COLITIS 27 0.0007
594 SENSATION OF FOREIGN BODY 6 0.0007
595 TENDONITIS 11 0.0007
596 HALLUCINATION, VISUAL 15 0.0007
597 CARDIOVASCULAR DISORDER 18 0.0007
598 BLOOD PRESSURE FLUCTUATION 17 0.0007
599 LUNG INFECTION 11 0.0007
600 MITRAL VALVE INCOMPETENCE 8 0.0007
601 HEART RATE INCREASED 70 0.0007
602 BLADDER DISORDER 7 0.0007
603 BLOOD PRESSURE ABNORMAL 14 0.0007
604 HYPERTENSION 149 0.0007
605 RESPIRATORY DISORDER 21 0.0007
606 MEDICATION ERROR 39 0.0007
607 HYPOGLYCAEMIA 34 0.0007
608 CONVULSION 40 0.0007
609 HEAD INJURY 22 0.0007
610 WHITE BLOOD CELL COUNT DECREASED 75 0.0007
611 RESPIRATORY TRACT INFECTION 18 0.0007
612 EYELID OEDEMA 8 0.0007
613 BLOOD PRESSURE INCREASED 105 0.0007
614 OEDEMA 37 0.0007
615 COLD SWEAT 12 0.0007
616 LOSS OF CONSCIOUSNESS 87 0.0007
617 BLISTER 38 0.0007
618 NEUROLEPTIC MALIGNANT SYNDROME 8 0.0007
619 CARDIOTOXICITY 6 0.0007
620 CHOLECYSTITIS 8 0.0007
621 RHABDOMYOLYSIS 28 0.0007
622 HAEMORRHOIDS 13 0.0007
623 DRUG LEVEL INCREASED 11 0.0007
624 HYPOAESTHESIA ORAL 10 0.0007
625 PELVIC PAIN 12 0.0007
626 VOMITING 310 0.0007
627 PRODUCT AVAILABILITY ISSUE 15 0.0007
628 RASH GENERALISED 17 0.0007
629 NO THERAPEUTIC RESPONSE 8 0.0007
630 RESTLESSNESS 24 0.0007
631 AGITATION 48 0.0007
632 RESPIRATORY ARREST 18 0.0007
633 MUSCLE TWITCHING 15 0.0007
634 DIVERTICULITIS 18 0.0006
635 BRONCHITIS 48 0.0006
636 ABNORMAL WEIGHT GAIN 8 0.0006
637 ATRIAL FIBRILLATION 63 0.0006
638 MUSCULOSKELETAL CHEST PAIN 10 0.0006
639 NECK PAIN 36 0.0006
640 BLOOD CREATININE INCREASED 42 0.0006
641 PRODUCT ADMINISTRATION ERROR 13 0.0006
642 TOOTH EXTRACTION 8 0.0006
643 ASPIRATION 7 0.0006
644 BLINDNESS UNILATERAL 9 0.0006
645 RENAL FAILURE 84 0.0006
646 HYPERGLYCAEMIA 23 0.0006
647 CHEST PAIN 116 0.0006
648 INTESTINAL PERFORATION 7 0.0006
649 REBOUND EFFECT 7 0.0006
650 SCAB 7 0.0006
651 BODY TEMPERATURE DECREASED 6 0.0006
652 STAPHYLOCOCCAL INFECTION 20 0.0006
653 HYPERSENSITIVITY 112 0.0006
654 EYE PAIN 34 0.0006
655 NASAL CONGESTION 35 0.0006
656 LYMPHADENOPATHY 21 0.0006
657 CONJUNCTIVITIS 11 0.0006
658 FEEDING DISORDER 12 0.0006
659 DRUG LEVEL DECREASED 6 0.0006
660 PLASMA CELL MYELOMA 23 0.0006
661 INSURANCE ISSUE 9 0.0006
662 PRODUCT PRESCRIBING ERROR 14 0.0006
663 SWELLING 55 0.0006
664 POLYNEUROPATHY 7 0.0006
665 BLOOD SODIUM DECREASED 11 0.0006
666 PERIPHERAL COLDNESS 8 0.0006
667 DYSPHONIA 34 0.0006
668 PARANOIA 10 0.0006
669 EJECTION FRACTION DECREASED 9 0.0006
670 PROTEINURIA 11 0.0006
671 PANCREATITIS ACUTE 13 0.0006
672 MUSCLE SPASMS 106 0.0006
673 PROCEDURAL PAIN 16 0.0006
674 FEELING COLD 16 0.0006
675 HERPES ZOSTER 33 0.0006
676 CARDIAC FAILURE 46 0.0006
677 HEART RATE DECREASED 20 0.0006
678 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
679 ABDOMINAL DISTENSION 59 0.0006
680 HEAD DISCOMFORT 10 0.0006
681 INTENTIONAL OVERDOSE 36 0.0006
682 PRODUCT USE IN UNAPPROVED INDICATION 139 0.0006
683 MALIGNANT NEOPLASM PROGRESSION 57 0.0006
684 LACTIC ACIDOSIS 18 0.0006
685 BACK PAIN 129 0.0006
686 BLOOD POTASSIUM INCREASED 9 0.0006
687 FAECES DISCOLOURED 12 0.0006
688 MENTAL DISORDER 24 0.0006
689 PREGNANCY 11 0.0005
690 CHEST DISCOMFORT 56 0.0005
691 PHOTOSENSITIVITY REACTION 9 0.0005
692 CONFUSIONAL STATE 88 0.0005
693 CARDIOMYOPATHY 8 0.0005
694 MENTAL STATUS CHANGES 15 0.0005
695 FEELING HOT 33 0.0005
696 INFLUENZA 60 0.0005
697 GENERAL PHYSICAL HEALTH DETERIORATION 62 0.0005
698 HEPATIC CIRRHOSIS 10 0.0005
699 TREATMENT FAILURE 44 0.0005
700 PULMONARY CONGESTION 7 0.0005
701 DYSPNOEA 299 0.0005
702 INFUSION RELATED REACTION 35 0.0005
703 GASTRIC ULCER 10 0.0005
704 QUALITY OF LIFE DECREASED 7 0.0005
705 FREQUENT BOWEL MOVEMENTS 14 0.0005
706 ELECTROLYTE IMBALANCE 6 0.0005
707 BLINDNESS 21 0.0005
708 LIVER FUNCTION TEST INCREASED 11 0.0005
709 FLATULENCE 29 0.0005
710 PALPITATIONS 59 0.0005
711 DRUG INEFFECTIVE 662 0.0005
712 COVID-19 88 0.0005
713 APHONIA 7 0.0005
714 ABSCESS 8 0.0005
715 CYTOKINE RELEASE SYNDROME 10 0.0005
716 CONTRAINDICATED PRODUCT ADMINISTERED 15 0.0005
717 TOOTH DISORDER 11 0.0005
718 DIARRHOEA 319 0.0005
719 DYSKINESIA 20 0.0005
720 ORAL PAIN 11 0.0005
721 RASH PAPULAR 11 0.0005
722 LUNG DISORDER 24 0.0005
723 EAR INFECTION 13 0.0005
724 OROPHARYNGEAL PAIN 45 0.0005
725 INFECTION 70 0.0005
726 NEUROPATHY PERIPHERAL 46 0.0005
727 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
728 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
729 PRODUCT USE ISSUE 90 0.0005
730 POISONING 6 0.0005
731 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
732 MOUTH ULCERATION 10 0.0005
733 DYSPHAGIA 45 0.0005
734 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
735 METRORRHAGIA 8 0.0005
736 NIGHT SWEATS 15 0.0005
737 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
738 THERAPEUTIC RESPONSE DECREASED 28 0.0005
739 OSTEOPENIA 7 0.0005
740 NEOPLASM PROGRESSION 16 0.0005
741 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
742 HIP ARTHROPLASTY 7 0.0005
743 BEDRIDDEN 6 0.0005
744 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
745 NEURALGIA 11 0.0005
746 DISTURBANCE IN ATTENTION 24 0.0004
747 MYELOSUPPRESSION 16 0.0004
748 BONE PAIN 26 0.0004
749 THROAT TIGHTNESS 12 0.0004
750 NAUSEA 351 0.0004
751 DECREASED APPETITE 103 0.0004
752 EXTRAPYRAMIDAL DISORDER 11 0.0004
753 MYALGIA 75 0.0004
754 WEIGHT DECREASED 123 0.0004
755 MUSCULAR WEAKNESS 50 0.0004
756 TREMOR 73 0.0004
757 URINARY TRACT INFECTION 75 0.0004
758 URINARY INCONTINENCE 13 0.0004
759 ERYTHEMA 90 0.0004
760 SOMNOLENCE 88 0.0004
761 SUICIDAL IDEATION 40 0.0004
762 TINNITUS 20 0.0004
763 COUGH 122 0.0004
764 BLOOD POTASSIUM DECREASED 13 0.0004
765 STOMATITIS 26 0.0004
766 RASH 186 0.0004
767 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
768 RETCHING 9 0.0004
769 JOINT INJURY 9 0.0004
770 TREATMENT NONCOMPLIANCE 23 0.0004
771 DEHYDRATION 56 0.0004
772 AGGRESSION 21 0.0004
773 LETHARGY 24 0.0004
774 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
775 DYSPEPSIA 41 0.0004
776 ANOSMIA 6 0.0004
777 HYPOAESTHESIA 62 0.0004
778 LOCALISED INFECTION 10 0.0004
779 INJECTION SITE HAEMATOMA 6 0.0004
780 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
781 MENTAL IMPAIRMENT 10 0.0004
782 FLUID OVERLOAD 6 0.0004
783 PANIC ATTACK 15 0.0004
784 CONDITION AGGRAVATED 125 0.0004
785 MALAISE 180 0.0004
786 ARTHRALGIA 170 0.0004
787 DYSURIA 15 0.0004
788 COGNITIVE DISORDER 19 0.0004
789 CONSTIPATION 88 0.0004
790 VISUAL IMPAIRMENT 50 0.0004
791 FLUSHING 41 0.0004
792 OSTEOARTHRITIS 17 0.0004
793 AGEUSIA 10 0.0004
794 RASH MACULAR 14 0.0004
795 PRODUCTIVE COUGH 19 0.0004
796 ILLNESS 41 0.0004
797 INSOMNIA 106 0.0004
798 PERIPHERAL SWELLING 61 0.0004
799 IMPAIRED HEALING 13 0.0004
800 LOWER RESPIRATORY TRACT INFECTION 18 0.0004
801 CEREBROVASCULAR ACCIDENT 67 0.0004
802 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
803 THIRST 7 0.0004
804 NASOPHARYNGITIS 72 0.0004
805 GOUT 7 0.0004
806 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
807 HEADACHE 244 0.0004
808 DIZZINESS 193 0.0004
809 ANGINA PECTORIS 11 0.0004
810 END STAGE RENAL DISEASE 7 0.0004
811 PRODUCT USE COMPLAINT 6 0.0004
812 SINUSITIS 39 0.0004
813 KNEE ARTHROPLASTY 8 0.0004
814 DISEASE RECURRENCE 18 0.0004
815 DISCOMFORT 23 0.0004
816 OBESITY 6 0.0004
817 HEPATIC STEATOSIS 7 0.0004
818 SENSORY DISTURBANCE 6 0.0004
819 MOVEMENT DISORDER 12 0.0004
820 FALL 124 0.0004
821 POOR QUALITY SLEEP 8 0.0004
822 SKIN DISCOLOURATION 17 0.0004
823 ABDOMINAL DISCOMFORT 62 0.0004
824 ANXIETY 105 0.0004
825 PARAESTHESIA 58 0.0004
826 DIABETES MELLITUS 28 0.0004
827 HEPATIC ENZYME INCREASED 25 0.0004
828 CHOLELITHIASIS 12 0.0004
829 SPEECH DISORDER 19 0.0004
830 TOXICITY TO VARIOUS AGENTS 61 0.0004
831 VIRAL INFECTION 12 0.0004
832 POLLAKIURIA 15 0.0004
833 PANCREATITIS 19 0.0004
834 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
835 ORAL HERPES 7 0.0004
836 GASTROINTESTINAL DISORDER 32 0.0004
837 CELLULITIS 18 0.0004
838 HYPERHIDROSIS 46 0.0004
839 TYPE 2 DIABETES MELLITUS 12 0.0004
840 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
841 LIMB DISCOMFORT 11 0.0004
842 CANDIDA INFECTION 6 0.0004
843 FEMUR FRACTURE 11 0.0004
844 DISABILITY 7 0.0004
845 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
846 WEIGHT INCREASED 79 0.0004
847 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
848 UPPER LIMB FRACTURE 7 0.0004
849 MYOCARDIAL INFARCTION 61 0.0003
850 INFLAMMATION 18 0.0003
851 SUICIDE ATTEMPT 21 0.0003
852 DYSPNOEA EXERTIONAL 13 0.0003
853 MUSCULOSKELETAL PAIN 18 0.0003
854 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
855 METASTASES TO LIVER 6 0.0003
856 RIB FRACTURE 7 0.0003
857 RENAL INJURY 10 0.0003
858 VISION BLURRED 46 0.0003
859 GAIT DISTURBANCE 64 0.0003
860 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 60 0.0003
861 IRRITABILITY 20 0.0003
862 RASH PRURITIC 18 0.0003
863 EXPIRED PRODUCT ADMINISTERED 11 0.0003
864 ABDOMINAL PAIN UPPER 68 0.0003
865 CRYING 12 0.0003
866 MOOD ALTERED 9 0.0003
867 FIBROMYALGIA 8 0.0003
868 PAIN 200 0.0003
869 PAIN IN EXTREMITY 95 0.0003
870 DEPRESSED MOOD 17 0.0003
871 DYSARTHRIA 12 0.0003
872 HALLUCINATION 24 0.0003
873 HOT FLUSH 24 0.0003
874 ABDOMINAL PAIN LOWER 8 0.0003
875 MUSCULOSKELETAL DISORDER 6 0.0003
876 COMA 15 0.0003
877 ROAD TRAFFIC ACCIDENT 13 0.0003
878 CHROMATURIA 7 0.0003
879 SKIN ULCER 8 0.0003
880 RHINORRHOEA 20 0.0003
881 DYSTONIA 6 0.0003
882 EAR PAIN 6 0.0003
883 DIPLOPIA 8 0.0003
884 DEAFNESS 8 0.0003
885 PRURITUS 117 0.0003
886 ANHEDONIA 8 0.0003
887 ABORTION SPONTANEOUS 12 0.0003
888 JOINT SWELLING 36 0.0003
889 FULL BLOOD COUNT DECREASED 6 0.0003
890 FEAR 8 0.0003
891 FATIGUE 230 0.0003
892 GASTRIC DISORDER 10 0.0003
893 SURGERY 17 0.0003
894 NERVOUS SYSTEM DISORDER 9 0.0003
895 ASTHENIA 108 0.0003
896 NO ADVERSE EVENT 52 0.0003
897 DERMATITIS 6 0.0003
898 LIVER INJURY 7 0.0003
899 HYPOTHYROIDISM 9 0.0003
900 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
901 CHRONIC KIDNEY DISEASE 21 0.0003
902 OCULAR HYPERAEMIA 13 0.0003
903 ACCIDENTAL OVERDOSE 10 0.0003
904 GASTROOESOPHAGEAL REFLUX DISEASE 22 0.0003
905 BURNING SENSATION 19 0.0003
906 INTESTINAL OBSTRUCTION 10 0.0003
907 MOBILITY DECREASED 19 0.0003
908 NEPHROLITHIASIS 12 0.0003
909 MENSTRUATION IRREGULAR 7 0.0003
910 DRUG INTOLERANCE 25 0.0003
911 OVERDOSE 55 0.0003
912 CYSTITIS 8 0.0003
913 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
914 AMNESIA 16 0.0002
915 EYE DISORDER 8 0.0002
916 INFLUENZA LIKE ILLNESS 20 0.0002
917 MUSCULOSKELETAL STIFFNESS 21 0.0002
918 GAIT INABILITY 8 0.0002
919 ASTHMA 27 0.0002
920 CARDIAC FAILURE CONGESTIVE 19 0.0002
921 FLUID RETENTION 12 0.0002
922 HEPATITIS 6 0.0002
923 FEELING ABNORMAL 56 0.0002
924 CORONARY ARTERY DISEASE 7 0.0002
925 INJECTION SITE RASH 7 0.0002
926 INJURY 16 0.0002
927 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
928 BALANCE DISORDER 19 0.0002
929 UNDERDOSE 16 0.0002
930 LUNG NEOPLASM MALIGNANT 9 0.0002
931 ARTHRITIS 17 0.0002
932 OSTEONECROSIS 7 0.0002
933 VISUAL ACUITY REDUCED 7 0.0002
934 THERAPY INTERRUPTED 15 0.0002
935 NEOPLASM MALIGNANT 14 0.0002
936 DEPRESSION 47 0.0002
937 LABORATORY TEST ABNORMAL 6 0.0002
938 EMOTIONAL DISORDER 6 0.0002
939 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
940 MEMORY IMPAIRMENT 26 0.0002
941 DEATH 161 0.0002
942 UNEVALUABLE EVENT 14 0.0002
943 RHEUMATOID ARTHRITIS 21 0.0002
944 CATARACT 11 0.0002
945 BREAST CANCER 17 0.0002
946 COLITIS ULCERATIVE 8 0.0002
947 THERAPY CESSATION 9 0.0002
948 DRY MOUTH 14 0.0002
949 RENAL DISORDER 8 0.0002
950 ACNE 13 0.0002
951 OSTEOPOROSIS 7 0.0002
952 DEVICE EXPULSION 11 0.0002
953 WITHDRAWAL SYNDROME 7 0.0002
954 INCORRECT DOSE ADMINISTERED 38 0.0002
955 ALOPECIA 32 0.0002
956 PRODUCT DOSE OMISSION ISSUE 46 0.0002
957 ILL-DEFINED DISORDER 9 0.0001
958 DRUG WITHDRAWAL SYNDROME 13 0.0001
959 PSORIATIC ARTHROPATHY 6 0.0001
960 ARTHROPATHY 8 0.0001
961 SKIN EXFOLIATION 12 0.0001
962 SLEEP DISORDER 10 0.0001
963 ADVERSE EVENT 13 0.0001
964 EMOTIONAL DISTRESS 17 0.0001
965 HYPOACUSIS 6 0.0001
966 VERTIGO 8 0.0001
967 INJECTION SITE REACTION 9 0.0001
968 DRUG EFFECT DECREASED 7 0.0001
969 BLOOD CHOLESTEROL INCREASED 6 0.0001
970 BLOOD GLUCOSE INCREASED 24 0.0001
971 INTENTIONAL PRODUCT MISUSE 11 0.0001
972 DYSGEUSIA 9 0.0001
973 DRY SKIN 16 0.0001
974 INJECTION SITE SWELLING 9 0.0001
975 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
976 NERVOUSNESS 6 0.0001
977 INJECTION SITE PAIN 35 0.0001
978 DERMATITIS ATOPIC 6 0.0001
979 INJECTION SITE ERYTHEMA 13 0.0001
980 DEVICE ISSUE 9 0.0001
981 INJECTION SITE HAEMORRHAGE 8 0.0001
982 HOSPITALISATION 15 0.0001
983 DRUG ABUSE 8 0.0001
984 INJECTION SITE PRURITUS 6 0.0001
985 PRODUCT QUALITY ISSUE 12 0.0001
986 CARDIAC DISORDER 8 0.0001
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
988 ADVERSE DRUG REACTION 7 0.0001
989 INJECTION SITE BRUISING 6 0.0001
990 PSORIASIS 9 0.0001
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
992 DRUG DEPENDENCE 6 0.0000